期刊
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA
卷 33, 期 1, 页码 99-109出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.soc.2023.07.004
关键词
Hepatic resection; Hepatocellular carcinoma; Surgical resection; Portal vein tumor thrombosis
HCC is the third leading cause of cancer-related deaths worldwide and its prognosis is complex and diverse, requiring consideration of tumor burden, biology, liver function, and patient status in treatment decision-making.
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide and the fastest-rising cause of cancer related mortality in the United States.1,2 Factors determining outcome following HCC diagnosis are complex and heterogenous in nature, dependent not only on tumor burden and biology, but on underlying liver function and patient performance status. These complexities require maintaining a tenuous balance between tumor- and patient-related factors with decisions regarding treatment strategies best made in the context of a multidisciplinary Surgical resection is the one of the mainstay curative treatment options in patients with localized, early-stage HCC associated with 5 year overall survival rates
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据